Literature DB >> 2788642

Fluoxetine overdose in an adolescent.

M A Riddle, N Brown, D Dzubinski, A N Jetmalani, Y Law, J L Woolston.   

Abstract

The response to and management of an acute ingestion of a large quantity of fluoxetine hydrochloride in a 13-year-old boy with Tourette's syndrome and obsessive compulsive disorder is described. The patient's symptomatic course following the ingestion included a grand mal seizure, depressed ST segments on EKG, nausea, dizziness, and headache. In general, the fluoxetine was well tolerated: all of the symptoms and signs remitted spontaneously.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788642     DOI: 10.1097/00004583-198907000-00019

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  6 in total

Review 1.  The use of psychotropics in the medically ill.

Authors:  M J Robinson; J L Levenson
Journal:  Curr Psychiatry Rep       Date:  2000-06       Impact factor: 5.285

Review 2.  Pharmacological treatment of depression in children and adolescents.

Authors:  R L Findling; M D Reed; J L Blumer
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

Review 3.  Selecting an antidepressant for use in a patient with epilepsy. Safety considerations.

Authors:  S Curran; K de Pauw
Journal:  Drug Saf       Date:  1998-02       Impact factor: 5.606

Review 4.  Epidemiology and relative toxicity of antidepressant drugs in overdose.

Authors:  J A Henry
Journal:  Drug Saf       Date:  1997-06       Impact factor: 5.606

Review 5.  Treatment of obsessive-compulsive disorder in children and adolescents. A review of the literature.

Authors:  P H Thomsen
Journal:  Eur Child Adolesc Psychiatry       Date:  1996-06       Impact factor: 4.785

6.  Serum fluoxetine and norfluoxetine levels support the safety of fluoxetine in overdose.

Authors:  Stephanie Pope; Solomon G Zaraa
Journal:  Ann Gen Psychiatry       Date:  2016-11-09       Impact factor: 3.455

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.